Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 7, 2017; 23(21): 3876-3882
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3876
Table 1 General characteristics of patients with autoimmune hepatitis
ParameterAIH (n = 52)
Mean age in yr40.1 ± 12.8
Sex as female/male37 (71.2)/15 (28.8)
Laboratory findings
ALT as × ULN7.0 (IQR = 9.3)
AST as × ULN6.2 (IQR = 9.1)
ALP as × ULN1.3 (IQR = 1.7)
Total bilirubin as × ULN0.9 (IQR = 1.6)
Albumin in gr/dL3.8 (IQR = 0.8)
Serum IgG in gr/dL2035 (IQR = 840)
Platelet counts as × 103/mm3219.0 (IQR = 66.8)
INR1.1 (IQR = 0.2)
Autoimmune serology
ANA38 (73.1)
SMA20 (38.5)
Anti LKM-11 (2)
Histological features
İnterface hepatitis
Mild9 (17.3)
Moderate18 (34.6)
Severe25 (48.1)
Fibrosis score
06 (11.5)
19 (17.3)
211 (21.2)
316 (30.8)
410 (19.2)
Table 2 General characteristics and adenosine deaminase levels of the study population
AIH (n = 52)Controls (n = 28)P value
Age in years40.1 ± 12.845.1 ± 10.70.080
Sex, F/M as n (%)37 (71.2)/15 (28.8)24 (85.7)/4 (14.3)0.144
ADA level in U/L25.4 ± 9.612.8 ± 2.2< 0.001
Table 3 General features and laboratory findings of autoimmune hepatitis patients according to inflammatory activity
Interface hepatitis
P value
Mild (n = 9)Moderate (n = 18)Severe (n = 25)
Age in years39.3 ± 14.541.1 ± 11.039.7 ± 13.90.927
Sex, F/M6-312-66-190.759
ALT as × ULN3.9 (IQR = 1.6)7.3 (IQR = 11.3)10.9 (IQR = 12)0.0321
Serum IgG in gr/dL1810 (IQR = 745)1955 (IQR = 570)2390 (IQR = 1205)0.0291
ADA in U/L15.2 ± 3.523.1 ± 10.030.9 ± 7.0< 0.0011
ADA > 20 U/L, n (%)09 (50)24 (96)< 0.0011
Table 4 Receiver operating characteristic curve for adenosine deaminase level in diagnosis of severe interface hepatitis
Cut-off, U/LAUCSE95%CISensitivitySpecificityPPDNPDP value
24.550.880.060.77-0.998885.288.584.6< 0.0011
25.250.880.060.77-0.998488.985.787.5< 0.0011